272 Capital LP decreased its stake in shares of Endava plc (NYSE:DAVA - Free Report) by 95.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,500 shares of the company's stock after selling 138,646 shares during the quarter. 272 Capital LP's holdings in Endava were worth $201,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. State Street Corp increased its holdings in shares of Endava by 33.0% during the third quarter. State Street Corp now owns 80,148 shares of the company's stock worth $2,047,000 after purchasing an additional 19,884 shares during the period. Oppenheimer Asset Management Inc. acquired a new position in Endava in the fourth quarter valued at about $215,000. Natixis Advisors LLC grew its stake in Endava by 44.8% during the fourth quarter. Natixis Advisors LLC now owns 45,340 shares of the company's stock worth $1,401,000 after buying an additional 14,023 shares in the last quarter. Robeco Institutional Asset Management B.V. raised its position in shares of Endava by 13.9% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 204,300 shares of the company's stock valued at $6,313,000 after buying an additional 25,000 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Endava by 35.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 27,289 shares of the company's stock worth $843,000 after acquiring an additional 7,124 shares in the last quarter. Institutional investors own 62.23% of the company's stock.
Endava Trading Down 1.2 %
Endava stock traded down $0.23 during trading hours on Tuesday, reaching $18.77. 330,443 shares of the company's stock were exchanged, compared to its average volume of 465,112. The firm's 50 day simple moving average is $19.83 and its 200 day simple moving average is $26.15. Endava plc has a twelve month low of $16.60 and a twelve month high of $34.94. The company has a quick ratio of 1.90, a current ratio of 1.90 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $1.11 billion, a PE ratio of 170.67, a PEG ratio of 2.26 and a beta of 1.25.
Endava (NYSE:DAVA - Get Free Report) last issued its earnings results on Thursday, February 20th. The company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.32 by ($0.18). The business had revenue of $250.63 million during the quarter, compared to the consensus estimate of $197.33 million. Endava had a return on equity of 0.89% and a net margin of 0.74%. Research analysts predict that Endava plc will post 0.57 earnings per share for the current year.
Analysts Set New Price Targets
DAVA has been the subject of a number of research reports. Susquehanna dropped their target price on shares of Endava from $55.00 to $50.00 and set a "positive" rating for the company in a report on Friday, February 21st. Morgan Stanley boosted their target price on shares of Endava from $33.00 to $35.00 and gave the stock an "equal weight" rating in a research note on Friday, January 31st. Finally, Needham & Company LLC reduced their price objective on Endava from $43.00 to $38.00 and set a "buy" rating on the stock in a research report on Friday, February 21st. Four research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $38.51.
Read Our Latest Analysis on Endava
About Endava
(
Free Report)
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Featured Stories

Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.